Juno Research, LLC - Medical Center Office

Houston, Texas 77054

0 studies enrolling now · 3 studies all time

What they study most

ASCVD, Dyslipidemias, Familial Hypercholesterolemia, High Cholesterol, Hypercholesterolemia, Type 2 Diabetes

Studies at this site

• Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• Randomized Study of Obicetrapib in Combination With Ezetimibe — Completed
• A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics — Completed